Arachidonic acid prevents fatty liver induced by conjugated linoleic acid in mice

British Journal of Nutrition

Volumn 101, Issue 10, 2009, Pages 1558-1563

  Oikawa, Daichi ^a   Tsuyama, Shoichiro ^a   Akimoto, Yoriko ^a   Mizobe, Yurika ^a   Furuse, Mitsuhiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Arachidonic acid; Conjugated linoleic acid; Fatty liver; Mice; Obesity; Prostaglandin E2

Indexed keywords

ALANINE AMINOTRANSFERASE; ARACHIDONIC ACID; ASPARTATE AMINOTRANSFERASE; CONJUGATED LINOLEIC ACID; PROSTAGLANDIN E1; PROSTAGLANDIN E2; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FATTY LIVER; LIPID STORAGE; LIVER PROTECTION; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ARACHIDONIC ACID; CHOLESTEROL; DINOPROSTONE; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; LINOLEIC ACIDS, CONJUGATED; MALE; MICE; TRIGLYCERIDES;

MUS;

EID: 67649443913     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508091253     Document Type: Article

References (36)

1. Kepler CR, Hirons KP, McNell JJ, et al. (1966) Intermediates and products of the biohydrogenation of linoleic acid by butyrivibrio fibrisolvens. J Biol Chem 241, 1350-1354.
2. Kepler CR & Tove SB (1967) Biohydrogenation of unsaturated fatty acids. J Biol Chem 242, 5686-5692.
3. Eulitz K, Yurawecz MP, Sehat N, et al. (1999) Preparation, separation, and confirmation of the eight geometrical cis/trans conjugated linoleic acid isomers 8,10- through 11,13-18:2. Lipids 34, 873-877.
4. Nakanishi T, Oikawa D, Koutoku T, et al. (2004) γ-Linolenic acid prevents conjugated linoleic acid-induced fatty liver in mice. Nutrition 20, 390-393.
5. Oikawa D, Nakanishi T, Nakamura Y, et al. (2003) CLA and DHA modify skin properties in mice. Lipids 38, 609-614.
6. Pariza MW, Park Y & Cook ME (2001) The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283-298.
7. Tsuboyama-Kasaoka N, Takahashi M, Tanemura K, et al. (2000) Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.
8. Gurr MI, Harwood JL & Frayn KN (2002) Fatty acid structure and metabolism. In Lipid Biochemistry, 5th ed., pp. 77-83. Oxford: Blackwell Science.
9. Lukivskaya OY, Maskevich AA & Buko VU (2001) Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver. Alcohol 25, 99-105.
10. Masaki N, Ohta Y, Shirataki H, et al. (1992) Hepatocyte membrane stabilization by prostaglandin E1 and E2: Favorable effects on rat liver injury. Gastroenterology 102, 572-576.
11. Sugano M, Tsujita A, Yamasaki M, et al. (1998) Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33, 521-527.
12. Oikawa D, Nakanishi T, Nakamura Y, et al. (2005) Modification of skin composition by conjugated linoleic acid alone or with combination of other fatty acids in mice. Br J Nutr 94, 275-281.
13. Bligh EG & Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911-917.
14. Cao ZP, Wang F, Xiang XS, et al. (2007) Intracerebroventricular administration of conjugated linoleic acid (CLA) inhibits food intake by decreasing gene expression of NPY and AgRP. Neurosci Lett 418 217-221.
15. Park Y, Albright KJ, Liu W, et al. (1997) Effect of conjugated linoleic acid on body composition in mice. Lipids 32, 853-858.
16. Park Y, Storkson JM, Albright KJ, et al. (1999) Evidence that the trans-10, cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34, 235-241.
17. Brown JM, Halvorsen YD, Lea-Currie YR, et al. (2001) Trans- 10, cis-12, but not cis-9, trans-11, conjugated linoleic acid attenuates lipogenesis in primary cultures of stromal vascular cells from human adipose tissue. J Nutr 131, 2316-2321.
18. Park Y, Storkson JM, Ntambi JM, et al. (2000) Inhibition of hepatic stearoyl-CoA desaturase activity by trans-10, cis-12 conjugated linoleic acid and its derivatives. Biochim Biophys Acta 1486, 285-292.
19. Lin Y, Kreeft A, Schuurbiers JAE, et al. (2001) Different effects of conjugated linoleic acid isomers on lipoprotein lipase activity in 3T3-L1 adipocytes. J Nutr Biochem 12, 183-189.
20. House RL, Cassady JP, Eisen EJ, et al. (2005) Conjugated linoleic acid evokes de-lipidation through the regulation of genes controlling lipid metabolism in adipose and liver tissue. Obes Rev 6, 247-258.
21. Nagao K, Inoue N, Wang YM, et al. (2004) Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/ fa) rats. J Nutr 135, 9-13.
22. Hirao A, Yamasaki M, Chujo H, et al. (2004) Effect of dietary conjugated linoleic acid on liver regeneration after a partial hepatectomy in rats. J Nutr Sci Vitaminol 50, 9-12.
23. Lina BAR, Wolterbeek APM, Suwa Y, et al. (2006) Subchronic (13-week) oral toxicity study, preceded by an in utero exposure phase, with arachidonate-enriched triglyceride oil (SUNTGA40S) in rats. Food Chem Toxicol 44, 326-335.
24. Mater MK, Thelen AP & Jump DB (1999) Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression. J Lipid Res 40 1045-1052.
25. Sugawara Y, Kubota K, Ogura T, et al. (1998) Protective effect of prostaglandin E1 against ischemia/reperfusion-induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol 29, 969-976.
26. Kelley DS, Bartolini GL, Newman JW, et al. (2006) Fatty acid composition of liver, adipose tissue, spleen, and heart of mice fed diets containing t10, c12-, and c9, t11-conjugated linoleic acid. Prostaglandins Leukot Essen Fatty Acids 74, 331-338.
27. Stangl GI (2000) Conjugated linoleic acids exhibit a strong fat-tolean partitioning effect, reduce serum VLDL lipids and redistribute tissue lipids in food-restricted rats. J Nutr 130, 1140-1146.
28. Kinlaw WB, Quinn JL, Wells WA, et al. (2006) Minireview: Spot 14: a marker of aggressive breast cancer and a potential therapeutic target. Endocrinology 147, 4048-4055.
29. Takahashi Y, Kushiro M, Shinohara K, et al. (2003) Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid. Biochim Biophys Acta 1631, 265-273.
30. Clément L, Poirier H, Niot I, et al. (2002) Dietary trans 10, cis- 12 conjugated linoleic acid induces hyperinsulinemia and fatty liver in the mouse. J Lipid Res 43, 1400-1409.
31. Wendel AA, Purushotham A, Liu LF, et al. (2008) Conjugated linoleic acid fails to worsen insulin resistance but induces hepatic steatosis in the presence of leptin in ob/ob mice. J Lipid Res 49, 98-106.
32. Wu M, Wang X, Duan Q, et al. (2007) Arachidonic acid can significantly prevent early insulin resistance induced by a high-fat diet. Ann Nutr Metab 51, 270-276.
33. 2 in pancreatic β-cells. Cell Physiol Biochem 20, 607-616.
34. Ide T (2005) Interaction of fish oil and conjugated linoleic acid in affecting hepatic activity of lipogenic enzymes and gene expression in liver and adipose tissue. Diabetes 54, 412-423.
35. Yanagita T, Wang Y-M, Nagao K, et al. (2005) Conjugated linoleic acid-induced fatty liver can be attenuated by combination with docosahexaenoic acid in C57BL/6N mice. J Agric Food Chem 53, 9629-9633.
36. Vemuri M, Kelley DS, Mackey BE, et al. (2007) Docosahexaenoic acid (DHA) but not eicosapentaenoic acid (EPA) prevents trans-10, cis-12 conjugated linoleic acid (CLA)- induced insulin resistance in mice. Metab Syndr Relat Disord 5, 315-322.